AI assistant
Sending…
NextCure, Inc. — Director's Dealing 2019
May 9, 2019
35069_dirs_2019-05-08_dce415e5-e7d1-4bcb-a0a8-595bcb47b0b3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: NextCure, Inc. (NXTC)
CIK: 0001661059
Period of Report: 2019-05-08
Reporting Person: Webster Stephen W (Director)
More from NextCure, Inc.
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 12
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3
Major Shareholding Notification
2026
Jan 29